Abstract:BackgroundInhibition of sphingosine kinase 1 (SphK1), which catalyzes bioactive lipid sphingosine-1–phosphate (S1P), attenuates NLRP3 inflammasome activation. S1P exerts most of its function by binding to S1P receptors (S1PR1-5). The roles of S1P receptors in NLRP3 inflammasome activation remain unclear.Materials and methodsThe mRNA expressions of S1PRs in bone marrow-derived macrophages (BMDMs) were measured by real-time quantitative polymerase chain reaction (qPCR) assays. BMDMs were primed with LPS and stimulated with NLRP3 activators, including ATP, nigericin, and imiquimod. Interleukin-1β (IL-1β) in the cell culture supernatant was detected by enzyme-linked immunosorbent assay (ELISA). Intracellular potassium was labeled with a potassium indicator and was measured by confocal microscopy. Protein expression in whole-cell or plasma membrane fraction was measured by Western blot. Cecal ligation and puncture (CLP) was induced in C57BL/6J mice. Mortality, lung wet/dry ratio, NLRP3 activation, and bacterial loads were measured.ResultsMacrophages expressed all five S1PRs in the resting state. The mRNA expression of S1PR3 was upregulated after lipopolysaccharide (LPS) stimulation. Inhibition of S1PR3 suppressed NLRP3 and pro-IL-1β in macrophages primed with LPS. Inhibition of S1PR3 attenuated ATP-induced NLRP3 inflammasome activation, enhanced nigericin-induced NLRP3 activation, and did not affect imiquimod-induced NLRP3 inflammasome activation. In addition, inhibition of S1PR3 suppressed ATP-induced intracellular potassium efflux. Inhibition of S1PR3 did not affect the mRNA or protein expression of TWIK2 in LPS-primed BMDMs. ATP stimulation induced TWIK2 expression in the plasma membrane of LPS-primed BMDMs, and inhibition of S1PR3 impeded the membrane expression of TWIK2 induced by ATP. Compared with CLP mice treated with vehicle, CLP mice treated with the S1PR3 antagonist, TY52156, had aggravated pulmonary edema, increased bacterial loads in the lung, liver, spleen, and blood, and a higher seven-day mortality rate.ConclusionsInhibition of S1PR3 suppresses the expression of NLRP3 and pro-IL-1β during LPS priming, and attenuates ATP-induced NLRP3 inflammasome activation by impeding membrane trafficking of TWIK2 and potassium efflux. Although inhibition of S1PR3 decreases IL-1β maturation in the lungs, it leads to higher bacterial loads and mortality in CLP mice.

The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation

The two pore potassium channel THIK-1 regulates NLRP3 inflammasome activation

Inhibition of Sphingosine-1-phosphate Receptor 3 Suppresses ATP-induced NLRP3 Inflammasome Activation in Macrophages Via TWIK2-mediated Potassium Efflux

NMI and IFP35 serve as proinflammatory DAMPs during cellular infection and injury

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

Two-pore potassium channel TREK-1 (K2P2.1) regulates NLRP3 inflammasome activity in macrophages

Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation

ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome

The role of Cl- and K+ efflux in NLRP3 inflammasome and innate immune response activation

A novel mechanism for NLRP3 inflammasome activation

Extracellular histones promote TWIK2-dependent potassium efflux and associated NLRP3 activation in alveolar macrophages during sepsis-induced lung injury

K+ regulates Ca2+ to drive inflammasome signaling: dynamic visualization of ion flux in live cells

Mechanistic basis for potassium efflux-driven activation of the human NLRP1 inflammasome

NEK7-Mediated Activation of NLRP3 Inflammasome Is Coordinated by Potassium Efflux/Syk/JNK Signaling During Staphylococcus aureus Infection

Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction

Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis

AKT Controls NLRP3 Inflammasome Activation by Inducing DDX3X Phosphorylation

The pore-forming subunit Kir6.1 of the K-ATP channel negatively regulates the NLRP3 inflammasome to control insulin resistance by interacting with NLRP3

Biphasic JNK signaling reveals distinct MAP3K complexes licensing inflammasome formation and pyroptosis

The BK Channel Limits the Pro-Inflammatory Activity of Macrophages

IKKβ binds NLRP3 providing a shortcut to inflammasome activation for rapid immune responses